Xiaoou Wang
Overview
Explore the profile of Xiaoou Wang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
113
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Guo J, Jia Z, Yang Y, Wang N, Xue Y, Xiao L, et al.
Int Immunopharmacol
. 2025 Mar;
152:114415.
PMID: 40086060
Background: The global tuberculosis (TB) epidemic remains severe. We aimed to develop a therapeutic DNA vaccine as an adjunct to TB treatment to improve efficacy. Methods: The W545 DNA vaccine...
2.
Dong X, Wang X, Zheng X, Jiang H, Liu L, Ma N, et al.
Cell Biol Toxicol
. 2025 Mar;
41(1):58.
PMID: 40056273
Triple-negative breast cancer (TNBC) poses as a daunting and intricate manifestation of breast cancer, highlighted by few treatment options and a poor outlook. The crucial element in fostering tumor growth...
3.
Zhang M, Kang N, Yu X, Zhang X, Duan Q, Ma X, et al.
Nat Commun
. 2025 Jan;
16(1):366.
PMID: 39753557
No abstract available.
4.
Wang X, Li Z, Shen J, Liu L
Cell Biol Toxicol
. 2024 Dec;
41(1):11.
PMID: 39707066
Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy characterized by the clonal expansion of myeloid progenitor cells. Despite advancements in treatment, the prognosis for AML patients remains poor, highlighting...
5.
Yang Y, Xue Y, Wang X, Wang L, Wang J, Zhang J, et al.
Immun Inflamm Dis
. 2024 Nov;
12(11):e70074.
PMID: 39588938
Background: Vaccination is one of the effective measures to prevent latent tuberculosis infection (LTBI) from developing into active tuberculosis (TB). Applying bioinformatics methods to pre-evaluate the biological characteristics and immunogenicity...
6.
Zhang M, Kang N, Yu X, Zhang X, Duan Q, Ma X, et al.
Nat Commun
. 2024 Oct;
15(1):9261.
PMID: 39461948
TNF inhibitors have been used to treat autoimmune and autoinflammatory diseases. Here we report an unexpected mechanism underlying the therapeutic effects of TNF inhibitors in Behçet's disease (BD), an autoimmune...
7.
Zhang H, Wang J, Li X, Zhang D, Qi Y, Zhang Q, et al.
World J Surg Oncol
. 2024 Jul;
22(1):194.
PMID: 39054543
Background: Epidermal growth factor receptor (EGFR) fusions are rare but potentially actionable oncogenic drivers across multiple solid tumors. However, the distribution and molecular characteristics of EGFR fusions in Chinese patients...
8.
Wang X, Liu Y, Ao Y, Wang J, Liu J, Xu Y, et al.
Clin Exp Rheumatol
. 2024 May;
42(10):2040-2048.
PMID: 38757293
Objectives: This study aims to evaluate the efficacy and safety of infliximab (IFX) in patients with parenchymal neuro-Behçet's syndrome (p-NBS). Methods: We retrospectively analysed eleven p-NBS patients treated with IFX...
9.
Chen Y, Yao Y, Li T, Shu K, Yang X, Li S, et al.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi
. 2024 Mar;
41(3):312-316.
PMID: 38448020
Objective: To analyze the clinical phenotype and genetic characteristics of a Chinese pedigree affected with Hereditary antithrombin deficiency. Methods: A pedigree diagnosed at the the Second Affiliated Hospital of Wenzhou...
10.
Wang X, Xue M, Wang M, Zhang C, Li J, Xie H
Chemosphere
. 2024 Feb;
352:141404.
PMID: 38342148
Antibiotic residues and their chlorinated disinfection by-products (Cl-DBPs) have adverse effects on organisms in aquaculture water. Taking enrofloxacin (ENR) as target antibiotic, this study investigated the degradation and transformation of...